# Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura

> **NCT03172676** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 75 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Amoxicillin 50 mg/kg/day in 2 divided doses for 14 days.
- **DRUG:** Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days.
- **DRUG:** Proton pump inhibitor 1 mg/kg/day in 2 divided doses 1 month

## Key facts

- **NCT ID:** NCT03172676
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-08-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03172676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03172676, "Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03172676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*